candesartan and cyclic cmp

candesartan has been researched along with cyclic cmp in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Borrajo, A; Diaz-Ruiz, C; Guerra, MJ; Labandeira-Garcia, JL; Rodriguez-Perez, AI	1

Other Studies

1 other study(ies) available for candesartan and cyclic cmp

Article	Year
Microglial TNF-α mediates enhancement of dopaminergic degeneration by brain angiotensin. Glia, 2014, Volume: 62, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Cyclic CMP; Dopaminergic Neurons; Dose-Response Relationship, Drug; Enzyme Inhibitors; Kallikreins; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Microglia; Nerve Degeneration; Neurons; Neurotoxins; Pancreatic Extracts; Tetrazoles; Tumor Necrosis Factor-alpha	2014

Article

Year

Microglial TNF-α mediates enhancement of dopaminergic degeneration by brain angiotensin.

Glia, 2014, Volume: 62, Issue:1

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Cyclic CMP; Dopaminergic Neurons; Dose-Response Relationship, Drug; Enzyme Inhibitors; Kallikreins; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Microglia; Nerve Degeneration; Neurons; Neurotoxins; Pancreatic Extracts; Tetrazoles; Tumor Necrosis Factor-alpha

2014